The Society for Translational Medicine: the...

The Society for Translational Medicine: the assessment and prevention of venous thromboembolism after lung cancer surgery

Abstract

Cancer is an independent major risk factor for venous thromboembolism (VTE), which is the second leading cause of death in medically and surgically treated patients with cancer (1-5). The association between VTE and lung cancer has been reported more than 20 years ago (6,7).

Authors

Li H; Jiang G; Bölükbas S; Chen C; Chen H; Chen K; Chen J; Cui X; Fang W; Gao S

Journal

Journal of Thoracic Disease, Vol. 10, No. 5, pp. 3039–3053

Publisher

AME Publishing Company

Publication Date

May 1, 2018

DOI

10.21037/jtd.2018.05.38

ISSN

2072-1439

Associated Experts

Yaron Shargall

Professor, Faculty of Health Sciences

Visit profile

Labels